Stroke & Vascular

Excellence Forums

Leaders in the field sharing authoritative insights and institutional best practices.
In this podcast, Neurology Learning Network’s Stroke & Vascular Section Editor Amrou Sarraj, MD, interviews Professor Bruce Campbell, MBBS(Hons), BMedSc, PhD, about data for thrombolysis. They discuss a historic perspective on thrombolytic therapies, as well as various trials including the WAKE-UP trial, EXTEND-IA TNK parts 1 and 2, SWIFT DIRECT trial, MR CLEAN trials, and more.
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare beneficiaries aged 65 years or older with acute ischemic stroke.
Hooman Kamel, MD, talks about embolic strokes of undetermined source (ESUS), the current standard of care for diagnosing and treating ESUS, and the evolution of research around ESUS.
In this podcast, Louis Caplan, MD, from Beth Israel Deaconess Medical Center talks about detecting penetrating artery disease, prevention of events, and the antiplatelet agents used to treat such events.
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in order to identify appropriate candidates for endovascular therapy.
Time to stroke care is critical for saving patients’ lives. However, a largely debated topic is whether ambulances should bypass primary stroke centers for comprehensive stroke centers. Johanna T. Fifi, MD, answered our questions.
The evaluation of strokes includes MRI, echocardiography, transesophageal echocardiography, Holter monitoring, and hematologic studies.
Michelle Puchowicz, PhD, from the University of Tennessee, writes about how ketones or ketosis is induced by diet, how it might be neuroprotective, and the steps needed to know for sure.
Dr Daniel Beard and colleagues from the University of Oxford studied the potential effects of rapamycin on infarct volume in animal models. Here are his responses to 5 of our burning questions.
Dr George Fulk, associate professor in and chair of the Department of Physical Therapy at Clarkson University, speaks about post-stroke gait speed.